| Title: | Evidence of shared genetic factors in the etiology of gastrointestinal disorders and endometriosis and clinical implications for disease management |
| Journal: | Cell Reports Medicine |
| Published: | 30 Oct 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37909040/ |
| DOI: | https://doi.org/10.1016/j.xcrm.2023.101250 |
| URL: | http://www.cell.com/article/S2666379123004275/pdf |
Publication 9302
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
In clinical practice, the co-existence of endometriosis and gastrointestinal symptoms is often observed. Using large-scale datasets, we report a genetic correlation between endometriosis and irritable bowel syndrome (IBS), peptic ulcer disease (PUD), gastro-esophageal reflux disease (GORD), and a combined GORD/PUD medicated (GPM) phenotype. Mendelian randomization analyses support a causal relationship between genetic predisposition to endometriosis and IBS and GPM. Identification of shared risk loci highlights biological pathways that may contribute to the pathogenesis of both diseases, including estrogen regulation and inflammation, and potential therapeutic drug targets (CCKBR; PDE4B). Higher use of IBS, GORD, and PUD medications in women with endometriosis and higher use of hormone therapies in women with IBS, GORD, and PUD, support the co-occurrence of these conditions and highlight the potential for drug repositioning and drug contraindications. Our results provide evidence of shared disease etiology and have important clinical implications for diagnostic and treatment decisions for both diseases.</p>
8 Authors
- Fei Yang
- Yeda Wu
- Richard Hockey
- International Endometriosis Genetics Consortium
- Jenny Doust
- Gita D. Mishra
- Grant W. Montgomery
- Sally Mortlock
Enabling scientific discoveries that improve human health